IDiyas

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10463676 B1

PDFFull Text
Date of Patent:
Nov. 05, 2019

Filed:

Jan. 07, 2019

Modified-release dosage forms of 5-htagonists useful for weight management

Applicant:

Arena Pharmaceuticals, Inc., San Diego, CA (US);

Inventors:

Zezhi Jesse Shao, San Diego, CA (US);

Anthony C. Blackburn, San Diego, CA (US);

Andrew J. Grottick, Chula Vista, CA (US);

Michael E. Morgan, San Diego, CA (US);

Jaimie Karyn Rueter, San Diego, CA (US);

Anna Shifrina, Alameda, CA (US);

Scott Stirn, Rancho Santa Fe, CA (US);

Libo Yang, San Diego, CA (US);

Woo Hyun Yoon, San Diego, CA (US);

Assignee:

Arena Pharmaceuticals, Inc., San Diego, CA (US);

Attorney:

Fish & Richardson P.C.

Primary Examiner:

Gina C Justice

Int. Cl.
CPC ...
A61K 31/55 (2006.01); A61K 9/00 (2006.01); C07D 223/16 (2006.01); A61P 1/14 (2006.01); A61K 9/28 (2006.01); A61K 9/20 (2006.01); A23P 20/12 (2016.01); A61K 31/155 (2006.01); A61K 31/135 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/55 (2013.01); A23P 20/12 (2016.08); A61K 9/0053 (2013.01); A61K 9/2013 (2013.01); A61K 9/2018 (2013.01); A61K 9/2054 (2013.01); A61K 9/2846 (2013.01); A61K 9/2866 (2013.01); A61K 31/135 (2013.01); A61K 31/155 (2013.01); A61K 45/06 (2013.01); A61P 1/14 (2018.01); C07D 223/16 (2013.01);
Abstract

The present invention relates to methods for weight management that utilize modified-release dosage forms comprising (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts and crystalline forms thereof. The present invention further relates to (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine salts, crystalline forms thereof and modified-release dosage forms comprising them.

Find Patent Forward Citations

Loading…